HomePMCB • NASDAQ
Pharmacyte Biotech Inc
add
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Jan 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 960.25K | -48.62% |
Net income | -3.05M | -391.55% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Jan 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 16.76M | -72.63% |
Total assets | 43.83M | -38.58% |
Total liabilities | 3.58M | -79.17% |
Total equity | 40.25M | — |
Shares outstanding | 6.86M | — |
Price to book | 0.22 | — |
Return on assets | -4.85% | — |
Return on capital | -5.74% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Jan 2025info | Y/Y change |
|---|---|---|
Net income | -3.05M | -391.55% |
Cash from operations | -509.89K | -187.91% |
Cash from investing | 0.00 | 100.00% |
Cash from financing | -3.95M | 43.95% |
Net change in cash | -4.46M | 63.52% |
Free cash flow | -3.90M | -536.89% |
Previous close
$1.30
Year range
$1.22 - $2.55
Market cap
8.92M USD
Avg Volume
19.54K
P/E ratio
1.18
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
1996
Headquarters
Website
Employees
2
